Dahlia Ismail

Dahlia Ismail has a diverse work experience in the pharmaceutical industry. Dahlia started their career at Clinicalland as a trainee in 2004, followed by roles at Vivactis Etudes cliniques and GECEM CRO as a Clinical Research Associate (CRA). In 2006, they joined Abbott laboratories france as a CRA and CRO Manager. Dahlia then moved on to NOVAGALI PHARMA SA, where they worked as a Clinical Project Manager from 2007-2011 and as a Clinical Trial Head from 2011-2012. Since 2012, Dahlia has been working at Santen, initially as a Clinical Trial Head and later as a Senior Manager Medical Affairs. Currently, they hold the position of Associate Director Clinical Science - Global Biomedical Science, where they are involved in various aspects of the marketing authorization procedure and regulatory compliance for medical devices.

Dahlia Ismail completed an Inter university diploma in Statistics applied to clinical trials at Pierre and Marie Curie University in 2006. Prior to that, they earned a Master's degree in Cellular biology at Univ. PARIS XII from 1999 to 2004. The education history does not provide information about their time at ICSV.